MOH (Biotech stock) has been consolidating tightly at ATH. There is clear R/S in this name despite the recent market weakness. On the 65m chart, MOH cleared the HVN above 172 and looks primed for continuation next week. Went long at the HVN break and above the intraday higher high.
Entry - 172.96
Stop Loss - 165
Target - 200
I will continue to update this post as the trade develops.
Entry - 172.96
Stop Loss - 165
Target - 200
I will continue to update this post as the trade develops.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.